Weekly Market Recap: Week Ending March 13, 2026
This week, the market presented a nuanced picture, with bullish and bearish forces vying for dominance. Haruspex AI analyzed 110 stocks and found an average AI score of 64.7 out of 100, suggesting a slightly positive but not overwhelmingly bullish market sentiment. While 49% of the analyzed stocks exhibited bullish characteristics, significant directional shifts were observed across various sectors. This indicates a market struggling to establish a clear, unified trend.
Market Sentiment Shift
At the beginning of the week, Haruspex AI indicated stronger bullish signals across the board. However, as the week progressed, several factors contributed to a softening of this initial optimism. Economic data releases, including inflation figures and jobless claims, injected uncertainty into the market. Furthermore, geopolitical developments and sector-specific news events triggered notable price fluctuations, leading to a divergence in directional signals. This shift underscores the importance of real-time data analysis in navigating today's complex market landscape. The final tally saw 38 stocks emerge as the biggest weekly gainers, but 27 ended the week as the biggest losers, demonstrating the week's conflicting movements.
Winners of the Week
Despite the overall market ambivalence, several stocks demonstrated significant positive momentum. Here's a closer look at the top performers, according to Haruspex AI's analysis:
- Mastercard Inc. (MA): Mastercard emerged as a clear winner, with its Haruspex AI score soaring by 23 points to reach 74.0. This significant increase indicates strong bullish pressure. The data suggests a renewed investor confidence in Mastercard’s growth prospects, possibly driven by increasing digital payment adoption and expansion into new markets. The AI identified a surge in positive news sentiment and unusual trading volumes, which often precedes significant price movements. The outlook for Mastercard remains bullish.
- Amazon.com Inc. (AMZN): Amazon also witnessed a substantial gain in its Haruspex AI score, jumping 20 points to 71.0. This places Amazon firmly in bullish territory. The AI analysis indicates that positive news regarding Amazon Web Services (AWS) growth and successful expansion into new e-commerce segments were major drivers. Amazon’s demonstrated resilience in navigating supply chain challenges also contributed to the positive sentiment. The outlook for Amazon is bullish. A second Amazon equity also performed well, with a score increase of 17.0 to 68.0, suggesting broad investor confidence in the tech giant.
- Merck & Co. Inc. (MRK): Merck saw its Haruspex AI score increase by 17 points to a strong 75.0. The data indicates strong bullish pressure. This surge likely reflects positive clinical trial results for key drug candidates and optimism surrounding the company’s pipeline. The AI algorithms detected increasing institutional investor interest and positive analyst ratings, both contributing to the upward momentum. The outlook for Merck is bullish.
Losers of the Week
Conversely, several stocks experienced a decline in their Haruspex AI scores, indicating weakening market sentiment. Here's a breakdown of the top losers:
- Eli Lilly and Company (LLY): Eli Lilly's Haruspex AI score decreased by 17 points to 53.0. This puts the stock in neutral territory. The AI analysis suggests that this decline was primarily driven by concerns regarding potential regulatory hurdles for its new drug approvals and increased competition in key therapeutic areas. While the company's fundamentals remain strong, short-term market sentiment has turned cautious. The outlook for Eli Lilly is neutral.
- Visa Inc. (V): Visa saw its Haruspex AI score fall by 11 points to 60.0, teetering on the edge of a bullish signal. The data indicates that concerns surrounding increased regulatory scrutiny of payment processing fees and the rise of alternative payment systems contributed to this decline. While Visa maintains a dominant market position, investors are closely monitoring potential challenges to its long-term growth. The outlook for Visa is neutral.
- Broadcom Inc. (AVGO): Broadcom's Haruspex AI score also dropped by 11 points to 56.0. This decline likely reflects concerns about the potential impact of slowing global economic growth on semiconductor demand. While Broadcom's diversified product portfolio provides some insulation, the company is not immune to broader macroeconomic trends. The outlook for Broadcom is neutral.
- Thermo Fisher Scientific (TMO): The score for Thermo Fisher Scientific was down 11 points to 55.0. The company’s decreased AI score seems to indicate that investors were concerned over potentially lowered demand for its products, stemming from healthcare consolidation and government spending cuts. The outlook for TMO is neutral.
- Exxon Mobil Corporation (XOM): The energy giant experienced a 10-point score drop to 55.0. This was potentially the effect of downward pressure on crude oil prices after rising inventories worldwide. The outlook for XOM is neutral.
Key Takeaways
- Sector Rotation: This week's market activity highlighted a clear sector rotation, with technology and healthcare outperforming while some financial and industrial sectors lagged behind.
- Data Sensitivity: Market sentiment proved highly sensitive to economic data releases, emphasizing the importance of staying informed and adapting investment strategies accordingly.
- Individual Stock Analysis is Critical: While overall market trends provide a useful context, individual stock analysis remains crucial for identifying opportunities and managing risk. Haruspex AI offers the depth of insight required to filter out the noise.
Week Ahead Outlook
Looking ahead, investors should closely monitor the following:
- Inflation Data: Upcoming inflation reports will be closely scrutinized for clues about the Federal Reserve's monetary policy trajectory.
- Geopolitical Developments: Ongoing geopolitical tensions could trigger market volatility and impact commodity prices.
- Earnings Season: As earnings season approaches, company-specific results and management guidance will provide valuable insights into the health of individual businesses and the broader economy.
